Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage.
Mutations in the transcription factor SOX10 cause neurocristopathies, including Waardenburg-Hirschsprung syndrome and peripheral neuropathies in humans. This is partly attributed to a requirement for Sox10 in early neural crest for survival, maintenance of pluripotency, and specification to several cell lineages, including peripheral glia. As a consequence, peripheral glia are absent in Sox10-deficient mice. Intriguingly, Sox10 continues to be expressed in these cells after specification. To analyze glial functions after specification, we specifically deleted Sox10 in immature Schwann cells by conditional mutagenesis. Mutant mice died from peripheral neuropathy before the seventh postnatal week. Nerve alterations included a thinned perineurial sheath, increased lipid and collagen deposition, and a dramatically altered cellular composition. Nerve conduction was also grossly aberrant, and neither myelinating nor nonmyelinating Schwann cells formed. Instead, axons of different sizes remained unsorted in large bundles. Schwann cells failed to develop beyond the immature stage and were unable to maintain identity. Thus, our study identifies a novel cause for peripheral neuropathies in patients with SOX10 mutations.
Finzsch
Markus
M
Institut für Biochemie, Emil-Fischer-Zentrum, Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Schreiner
Silke
S
Kichko
Tatjana
T
Reeh
Peter
P
Tamm
Ernst R
ER
Bösl
Michael R
MR
Meijer
Dies
D
Wegner
Michael
M
D000818:Animals; D002454:Cell Differentiation; D019070:Cell Lineage; D004622:Embryo, Mammalian / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D009154:Mutation; D010523:Peripheral Nervous System Diseases / Q000235:genetics; D051381:Rats; D055757:SOXE Transcription Factors / Q000235:genetics*; D012583:Schwann Cells / Q000166:cytology* / Q000378:metabolism
D055757:SOXE Transcription Factors
Nat Genet. 1998 Jan;18(1):60-4
9425902
J Immunol. 1996 Feb 15;156(4):1515-24
8568255
Neurochem Res. 2007 Jul;32(7):1129-41
17404841
J Neurosci Methods. 1990 Feb;31(2):109-18
2319811
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5161-5
9560246
J Neurosci. 1998 Jan 1;18(1):237-50
9412504
J Cell Biol. 2002 Jan 7;156(1):199-209
11777940
Nucleic Acids Res. 1999 Mar 15;27(6):1409-20
10037800
Development. 2004 Nov;131(22):5599-612
15496445
Nat Genet. 1998 Feb;18(2):171-3
9462749
J Neurochem. 2010 Feb;112(3):744-54
19922439
Nat Genet. 2000 Jun;25(2):139-40
10835623
Mol Cell Biol. 2005 Mar;25(5):1821-9
15713637
Genes Dev. 2003 Jun 1;17(11):1380-91
12782656
Mol Cell Biol. 2007 May;27(9):3521-9
17325040
EMBO Rep. 2006 Jan;7(1):52-8
16311519
Genes Dev. 2002 Jan 15;16(2):165-70
11799060
Nat Genet. 2004 Apr;36(4):361-9
15004559
Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2596-601
15695336
J Cell Biol. 2007 Jun 18;177(6):1051-61
17576798
Mol Cell Biol. 2000 May;20(9):3198-209
10757804
Genes Dev. 2001 Jan 1;15(1):66-78
11156606
Am J Hum Genet. 2007 Dec;81(6):1169-85
17999358
Genesis. 2004 Nov;40(3):171-5
15493017
Nat Rev Neurosci. 2005 Sep;6(9):671-82
16136171
Science. 2009 Jan 30;323(5914):651-4
19179536
Nature. 1994 Oct 27;371(6500):796-9
7935840
J Anat. 1997 Oct;191 ( Pt 3):321-36
9418989
Development. 2001 Oct;128(20):3949-61
11641219
Glia. 2008 Nov 1;56(14):1566-77
18803324
BMC Dev Biol. 2001;1:4
11299042
Neurobiol Dis. 2009 Mar;33(3):448-58
19111616
Science. 1996 Jul 26;273(5274):507-10
8662541
J Cell Biol. 2007 Jun 18;177(6):1063-75
17576799
Dev Biol. 2010 May 1;341(1):267-81
20144603
Neuron. 2003 Apr 10;38(1):17-31
12691661
Genes Dev. 1996 Jul 15;10(14):1751-62
8698235
Dev Biol. 2000 Nov 15;227(2):239-55
11071752
Dev Biol. 2005 Jan 1;277(1):155-69
15572147
Neuron. 1999 Aug;23(4):713-24
10482238
Development. 2007 Sep;134(18):3271-81
17699610
Development. 2006 Aug;133(15):2875-86
16790476
Pediatr Dev Pathol. 1999 Nov-Dec;2(6):559-69
10508880